Spheroidsin the macroporousHAGal sponge must be retrieved for further characterization. Development of a degradable/cleavable sponge is needed to recover thespheroidsmore easily.Drug adsorptionon the HA Gal sponge has been observed and a thorough investigation on the mechanism and kinetics of drug adsorption is in progress. Decreasing the sponge size in smaller well plates can partially remedy the problem, i.e., 96-well and 384-well sponges can have less serious drug absorption than 48- or 24-well size sponge. Surface modification of the sponge may be required to minimize drug adsorption when using the sponge to form spheroids for drug testing. For membrane-constrained spheroids, the surface treatment is less critical in reducing drug absorption, especially for ultrathin porous membrane. The surface treatment is more important for controlling the cell-substrate interaction and maintainingspheroidsize and cellular functions. Another issue one needs to be careful is the fragility of the ultrathin porous membrane. Even though Parylene C is much less brittle than silicon nitride (Si3N4) membrane that we have developed previously (Zhang et al., 2008), and we have reinforced its mechanical stability by building thicker frames into the Parylene C membrane, one still needs to handle it carefully.